title: How can rates of prostate-specific antigen screening be reduced in men aged 80 and older?
authors.forename: Jeff
authors.initials: J
authors.lastname: Whittle
authors.forename: Clement J
authors.initials: CJ
authors.lastname: Zablocki
mesh_terms: D000369:Aged, 80 and over; D015276:Health Care Rationing; D006300:Health Services Misuse / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000706:statistics & numerical data*; D010342:Patient Acceptance of Health Care; D018579:Patient Selection; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000401:mortality; D014481:United States / Q000453:epidemiology
chemical_list: D017430:Prostate-Specific Antigen